DK0909323T3
(da)
|
1996-01-04 |
2007-05-21 |
Novartis Vaccines & Diagnostic |
Helicobacter pylori-bakterioferritin
|
US5882892A
(en)
*
|
1997-07-23 |
1999-03-16 |
Smithkline Beecham Corporation |
Asps
|
US6001602A
(en)
*
|
1997-07-23 |
1999-12-14 |
Smithkline Beecham Corporation |
DNA encoding Chlamydia trachomatis isoleucyl tRNA synthetase polypeptides
|
EP2218732A1
(en)
*
|
1997-11-28 |
2010-08-18 |
Merck Serono Biodevelopment |
Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
|
US6660275B2
(en)
*
|
1998-07-27 |
2003-12-09 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
AU4793499A
(en)
*
|
1998-07-27 |
2000-02-21 |
Aventis Pasteur Limited |
(chlamydia) antigens and corresponding dna fragments and uses thereof
|
WO2000006739A2
(en)
*
|
1998-07-27 |
2000-02-10 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US20030147924A1
(en)
*
|
1998-07-27 |
2003-08-07 |
Aventis Pasteur Limited/Aventis Pasteur Limitee |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
JP2002525027A
(ja)
*
|
1998-07-27 |
2002-08-13 |
コナート ラボラトリーズ リミテッド |
Chlamydia抗原および対応するDNAフラグメントならびにそれらの使用
|
WO2000011180A1
(en)
*
|
1998-08-20 |
2000-03-02 |
Connaught Laboratories Limited |
NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA)
|
AU5366099A
(en)
|
1998-08-20 |
2000-03-14 |
Connaught Laboratories Limited |
Nucleic acid molecules encoding inclusion membrane protein of (chlamydia)
|
WO2000011183A2
(en)
*
|
1998-08-20 |
2000-03-02 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US6686339B1
(en)
|
1998-08-20 |
2004-02-03 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
|
US6693087B1
(en)
|
1998-08-20 |
2004-02-17 |
Aventis Pasteur Limited |
Nucleic acid molecules encoding POMP91A protein of Chlamydia
|
US6649370B1
(en)
|
1998-10-28 |
2003-11-18 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6403101B1
(en)
*
|
1998-10-28 |
2002-06-11 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
WO2000024765A2
(en)
*
|
1998-10-28 |
2000-05-04 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US6872814B2
(en)
|
1998-10-29 |
2005-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6403102B1
(en)
|
1998-10-29 |
2002-06-11 |
Connaught Laboratories Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6607730B1
(en)
|
1998-11-02 |
2003-08-19 |
Aventis Pasteur Limited/Aventis Pasteur Limitee |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6822071B1
(en)
*
|
1998-11-12 |
2004-11-23 |
The Regents Of The University Of California |
Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
|
CA2353107A1
(en)
*
|
1998-12-01 |
2000-06-08 |
Andrew D. Murdin |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
EP1135509A2
(en)
*
|
1998-12-01 |
2001-09-26 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US6565856B1
(en)
|
1998-12-08 |
2003-05-20 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
CA2746535A1
(en)
|
1998-12-08 |
2000-06-15 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US20020061848A1
(en)
|
2000-07-20 |
2002-05-23 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6447779B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds for the diagnosis of Chlamydial infection
|
US6555115B1
(en)
|
1998-12-08 |
2003-04-29 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6432916B1
(en)
|
1998-12-08 |
2002-08-13 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
US6448234B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
EP1140999A1
(en)
|
1998-12-23 |
2001-10-10 |
Aventis Pasteur Limited |
$i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
|
US7297341B1
(en)
|
1998-12-23 |
2007-11-20 |
Sanofi Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
NZ512448A
(en)
*
|
1998-12-28 |
2004-01-30 |
Aventis Pasteur |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6808713B1
(en)
|
1998-12-28 |
2004-10-26 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
GB9902555D0
(en)
*
|
1999-02-05 |
1999-03-24 |
Neutec Pharma Plc |
Medicament
|
MXPA01009256A
(es)
|
1999-03-12 |
2003-07-14 |
Aventis Pasteur |
Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
|
JP4695763B2
(ja)
*
|
1999-05-03 |
2011-06-08 |
サノフィ、パストゥール、リミテッド |
クラミジア抗原および対応するdna断片ならびにその使用
|
WO2001002575A1
(en)
*
|
1999-06-30 |
2001-01-11 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
AU7398300A
(en)
*
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001021810A1
(en)
*
|
1999-09-17 |
2001-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
AU7398600A
(en)
*
|
1999-09-17 |
2001-04-24 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
EP1220924A1
(en)
*
|
1999-09-17 |
2002-07-10 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001021806A1
(en)
*
|
1999-09-17 |
2001-03-29 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
CA2385325C
(en)
|
1999-09-20 |
2012-04-10 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
US6632663B1
(en)
|
1999-09-22 |
2003-10-14 |
Aventis Pasteur Limited |
DNA immunization against chlamydia infection
|
AU7732000A
(en)
*
|
1999-09-29 |
2001-04-30 |
Mara Diaz |
Method of identifying pathogenic cryptococci
|
DK1094069T4
(da)
|
1999-10-18 |
2008-07-21 |
Intervet Int Bv |
DNA kodende for strukturelt protein-1 fra infektiös lakseanæmivirus og anvendelser deraf
|
WO2001036455A2
(en)
*
|
1999-11-12 |
2001-05-25 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001036457A2
(en)
*
|
1999-11-15 |
2001-05-25 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001036456A2
(en)
*
|
1999-11-15 |
2001-05-25 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
DE19959650A1
(de)
*
|
1999-12-10 |
2001-06-13 |
Degussa |
Neue für die Gene sdhA, sdhB und sdhC codierende Nukleotidsequenzen
|
WO2001046225A2
(en)
*
|
1999-12-22 |
2001-06-28 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
WO2001046226A2
(en)
*
|
1999-12-22 |
2001-06-28 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
CA2395499C
(en)
*
|
1999-12-22 |
2011-10-25 |
Aventis Pasteur Limited |
Chlamydia antigens and corresponding dna fragments and uses thereof
|
AU2001230531A1
(en)
*
|
2000-01-31 |
2001-08-14 |
Asahi Kasei Kabushiki Kaisha |
Antibody for detecting chlamydia pneumoniae
|
US20020071831A1
(en)
*
|
2000-04-04 |
2002-06-13 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020132994A1
(en)
*
|
2000-04-04 |
2002-09-19 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20030100706A1
(en)
*
|
2000-04-04 |
2003-05-29 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020082402A1
(en)
*
|
2000-04-04 |
2002-06-27 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US20020094965A1
(en)
*
|
2000-04-04 |
2002-07-18 |
Murdin Andrew D. |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6919187B2
(en)
|
2000-04-21 |
2005-07-19 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
ES2303525T3
(es)
|
2000-04-21 |
2008-08-16 |
Corixa Corporation |
Compuestos y metodos para el tratamiento y diagnostico de infeccion por chlamydia.
|
EP1792995A3
(en)
|
2000-05-08 |
2007-06-13 |
Sanofi Pasteur Limited |
Chlamydia secretory locus orf and uses thereof
|
ATE348892T1
(de)
*
|
2000-05-08 |
2007-01-15 |
Sanofi Pasteur Ltd |
Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
|
ATE440861T1
(de)
*
|
2000-07-03 |
2009-09-15 |
Novartis Vaccines & Diagnostic |
Immunisierung gegen chlamydia pneumoniae
|
AUPQ954000A0
(en)
*
|
2000-08-18 |
2000-09-14 |
Queensland University Of Technology |
Novel diagnostic agents and uses therefor
|
US6980674B2
(en)
|
2000-09-01 |
2005-12-27 |
Large Scale Proteomics Corp. |
Reference database
|
US6539102B1
(en)
|
2000-09-01 |
2003-03-25 |
Large Scale Proteomics |
Reference database
|
US7731980B2
(en)
|
2000-10-02 |
2010-06-08 |
Emergent Product Development Gaithersburg Inc. |
Chlamydia PMP proteins, gene sequences and uses thereof
|
US7537772B1
(en)
|
2000-10-02 |
2009-05-26 |
Emergent Product Development Gaithersburg Inc. |
Chlamydia protein, gene sequence and the uses thereof
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
US6682889B1
(en)
|
2000-11-08 |
2004-01-27 |
Becton, Dickinson And Company |
Amplification and detection of organisms of the Chlamydiaceae family
|
US20070149474A1
(en)
*
|
2000-12-15 |
2007-06-28 |
Auburn University |
Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
|
US20030059896A1
(en)
*
|
2000-12-21 |
2003-03-27 |
Shire Biochem Inc. |
Novel chlamydia antigens and corresponding DNA fragments
|
GB0102929D0
(en)
*
|
2001-02-06 |
2001-03-21 |
Inpharmatica Ltd |
Novel proteins
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
EP1412757A2
(en)
*
|
2001-04-09 |
2004-04-28 |
Allan Christian Shaw |
Method for identification of proteins from intracellular bacteria
|
US6891085B2
(en)
*
|
2001-04-20 |
2005-05-10 |
Pioneer Hi-Bred International, Inc. |
Nucleic acid encoding the FUS6 antimicrobial polypeptide of Agrotis ipsilon and its use to enhance disease resistance in a plant
|
GB0115176D0
(en)
|
2001-06-20 |
2001-08-15 |
Chiron Spa |
Capular polysaccharide solubilisation and combination vaccines
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
GB0121591D0
(en)
|
2001-09-06 |
2001-10-24 |
Chiron Spa |
Hybrid and tandem expression of neisserial proteins
|
RU2331435C2
(ru)
|
2001-12-12 |
2008-08-20 |
Чирон Срл. |
Иммунизация против chlamydia trachomatis
|
GB0203403D0
(en)
|
2002-02-13 |
2002-04-03 |
Chiron Spa |
Chlamydia cytotoxic-T cell epitopes
|
AU2003215316A1
(en)
|
2002-02-20 |
2003-09-09 |
Chiron Corporation |
Microparticles with adsorbed polypeptide-containing molecules
|
GB0220194D0
(en)
|
2002-08-30 |
2002-10-09 |
Chiron Spa |
Improved vesicles
|
AU2003287980B2
(en)
|
2002-11-01 |
2009-06-25 |
Glaxosmithkline Biologicals S.A. |
Drying process
|
EP2279746B1
(en)
|
2002-11-15 |
2013-10-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Surface proteins in neisseria meningitidis
|
GB0227346D0
(en)
|
2002-11-22 |
2002-12-31 |
Chiron Spa |
741
|
KR100532665B1
(ko)
*
|
2002-11-28 |
2005-12-02 |
주식회사 바이오메드랩 |
나이세리아속 균 탐지용 프로브, 이를 이용한나이세리아속 균의 유전형 분석키트 및 유전형 분석방법
|
WO2004060396A2
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Immunogenic compositions containing phospholpid
|
US20040208890A1
(en)
*
|
2003-02-24 |
2004-10-21 |
Institut Pasteur |
Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
|
US7893096B2
(en)
|
2003-03-28 |
2011-02-22 |
Novartis Vaccines And Diagnostics, Inc. |
Use of small molecule compounds for immunopotentiation
|
WO2004087924A2
(en)
*
|
2003-03-31 |
2004-10-14 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Method for delivery of substances to intracellular microorganisms
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
EP2179729B1
(en)
|
2003-06-02 |
2016-07-20 |
GlaxoSmithKline Biologicals SA |
Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen
|
EP2277595A3
(en)
|
2004-06-24 |
2011-09-28 |
Novartis Vaccines and Diagnostics, Inc. |
Compounds for immunopotentiation
|
WO2006115509A2
(en)
|
2004-06-24 |
2006-11-02 |
Novartis Vaccines And Diagnostics Inc. |
Small molecule immunopotentiators and assays for their detection
|
US20090317420A1
(en)
|
2004-07-29 |
2009-12-24 |
Chiron Corporation |
Immunogenic compositions for gram positive bacteria such as streptococcus agalactiae
|
PL1812058T3
(pl)
|
2004-10-25 |
2012-11-30 |
Statens Seruminstitut |
Antygeny Chlamydia trachomatis do stosowania w szczepionkach i diagnostyce
|
GB0424092D0
(en)
|
2004-10-29 |
2004-12-01 |
Chiron Srl |
Immunogenic bacterial vesicles with outer membrane proteins
|
GB0502095D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Conjugation of streptococcal capsular saccharides
|
GB0502096D0
(en)
|
2005-02-01 |
2005-03-09 |
Chiron Srl |
Purification of streptococcal capsular polysaccharide
|
NZ580974A
(en)
|
2005-02-18 |
2011-05-27 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic escherichia coli
|
DK1858920T3
(en)
|
2005-02-18 |
2016-02-29 |
Glaxosmithkline Biolog Sa |
PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS / SEPSIS-ASSOCIATED ESCHERICHIA COLI
|
JP2006273805A
(ja)
*
|
2005-03-30 |
2006-10-12 |
Yamaguchi Univ |
肺炎クラミジアのIncA2蛋白質、クラミジアのInc蛋白質群およびその利用方法
|
US8541007B2
(en)
|
2005-03-31 |
2013-09-24 |
Glaxosmithkline Biologicals S.A. |
Vaccines against chlamydial infection
|
EP1896612A2
(en)
|
2005-06-06 |
2008-03-12 |
Gen-Probe Incorporated |
Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample
|
CN101355960A
(zh)
|
2005-10-18 |
2009-01-28 |
诺华疫苗和诊断公司 |
使用α病毒复制子颗粒进行粘膜和全身免疫
|
US7527801B2
(en)
|
2005-11-22 |
2009-05-05 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and Sapovirus antigens
|
DE102006003814A1
(de)
*
|
2006-01-26 |
2007-08-02 |
Sirs-Lab Gmbh |
Verfahren zur in-vitro-Diagnose von Chlamydophila pneumoniae Infektionen
|
EP2357184B1
(en)
|
2006-03-23 |
2015-02-25 |
Novartis AG |
Imidazoquinoxaline compounds as immunomodulators
|
AU2007285484B2
(en)
|
2006-08-16 |
2013-05-02 |
Novartis Ag |
Immunogens from uropathogenic Escherichia coli
|
WO2008136867A2
(en)
*
|
2006-12-04 |
2008-11-13 |
Auburn University |
Chlamydia pneumoniae vaccine and methods for administering such a vaccine
|
GB0700562D0
(en)
|
2007-01-11 |
2007-02-21 |
Novartis Vaccines & Diagnostic |
Modified Saccharides
|
CA2690271A1
(en)
*
|
2007-06-18 |
2008-12-24 |
Intercell Ag |
Chlamydia antigens
|
CA2699513C
(en)
|
2007-09-12 |
2018-03-13 |
Novartis Ag |
Gas57 mutant antigens and gas57 antibodies
|
CA2744739A1
(en)
|
2007-12-03 |
2009-06-11 |
President And Fellows Of Harvard College |
Chlamydia antigens
|
EP2537857B1
(en)
|
2007-12-21 |
2017-01-18 |
GlaxoSmithKline Biologicals SA |
Mutant forms of streptolysin O
|
HUE044239T2
(hu)
|
2008-03-27 |
2019-10-28 |
Purdue Research Foundation |
Kollagén-kötõ szintetikus peptidoglikánok, elõállításuk és alkalmazási eljárásaik
|
PL2349520T3
(pl)
|
2008-10-27 |
2017-08-31 |
Glaxosmithkline Biologicals Sa |
Sposób oczyszczania węglowodanów z paciorkowców grupy a
|
US8585505B2
(en)
|
2008-12-15 |
2013-11-19 |
Tetris Online, Inc. |
Inter-game interactive hybrid asynchronous computer game infrastructure
|
EP2384120B1
(en)
|
2009-01-05 |
2019-12-11 |
Epitogenesis Inc. |
Adjuvant compositions and methods of use
|
AU2010204139A1
(en)
|
2009-01-12 |
2011-08-11 |
Novartis Ag |
Cna_B domain antigens in vaccines against gram positive bacteria
|
CN102438650A
(zh)
|
2009-03-06 |
2012-05-02 |
诺华有限公司 |
衣原体抗原
|
US8974799B2
(en)
|
2009-09-30 |
2015-03-10 |
Novartis Ag |
Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides
|
LT2493498T
(lt)
|
2009-10-30 |
2017-05-25 |
Glaxosmithkline Biologicals Sa |
Staphylococcus aureus 5 tipo ir 8 tipo kapsulinių sacharidų gryninimas
|
EP2558596B1
(en)
*
|
2010-04-16 |
2018-03-14 |
The Government Of The United States Of America As Reresented By The Secretary Of The Department Of Health & Human Services |
Real time pcr assay for detection of bacterial respiratory pathogens
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
US20130315959A1
(en)
|
2010-12-24 |
2013-11-28 |
Novartis Ag |
Compounds
|
JP6069307B2
(ja)
|
2011-05-24 |
2017-02-01 |
シミック・アイピー・リミテッド・ライアビリティー・カンパニーSymic Ip, Llc |
ヒアルロン酸結合合成ペプチドグリカン、その製造および使用方法
|
US10561720B2
(en)
|
2011-06-24 |
2020-02-18 |
EpitoGenesis, Inc. |
Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
|
TR201909110T4
(tr)
|
2011-09-14 |
2019-07-22 |
Glaxosmithkline Biologicals Sa |
Sakarit-protein glikokonjugatları yapmaya yönelik yöntemler.
|
JP6170932B2
(ja)
|
2011-11-07 |
2017-07-26 |
ノバルティス アーゲー |
spr0096抗原およびspr2021抗原を含むキャリア分子
|
US10124051B2
(en)
|
2012-05-22 |
2018-11-13 |
Glaxosmithkline Biologicals Sa |
Meningococcus serogroup X conjugate
|
US9200039B2
(en)
|
2013-03-15 |
2015-12-01 |
Symic Ip, Llc |
Extracellular matrix-binding synthetic peptidoglycans
|
US10835594B2
(en)
*
|
2014-01-16 |
2020-11-17 |
Mcmaster University |
Type III secretion injectisome proteins for treatment and prevention of chlamydial infections
|
US10772931B2
(en)
|
2014-04-25 |
2020-09-15 |
Purdue Research Foundation |
Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
|
BE1024634B1
(fr)
|
2016-04-05 |
2018-05-14 |
Gsk Vaccines S.R.L. |
Compositions immunogenes
|
US11529424B2
(en)
|
2017-07-07 |
2022-12-20 |
Symic Holdings, Inc. |
Synthetic bioconjugates
|
CN108875000B
(zh)
*
|
2018-06-14 |
2021-12-28 |
广东工业大学 |
一种融合多句法结构的语义关系分类方法
|
CN109180822B
(zh)
*
|
2018-11-14 |
2021-08-10 |
上海交通大学 |
一种猪链球菌b细胞优势表位串联疫苗及其制备方法
|
KR102422293B1
(ko)
*
|
2020-08-24 |
2022-07-18 |
수원대학교산학협력단 |
Erm 단백질과 상호작용하는 Helix 73 유래 RNA 분자 및 이의 이용 방법
|
CN112119907A
(zh)
*
|
2020-09-21 |
2020-12-25 |
连云港市农业科学院 |
一种洋葱全不育制种方法
|
CN114137209B
(zh)
*
|
2021-02-01 |
2024-03-01 |
中国水产科学研究院黄海水产研究所 |
一种快速检测牡蛎疱疹病毒抗原的免疫荧光检测试纸条及应用
|